Synonyms: (4Z)-7-[(1R,2R,3S,5S)-5-([1,1'-Biphenyl]-4-ylmethoxy)-3-hydroxy-2-(1-piperidinyl)cyclopentyl]-4-heptenoic acid hydrochloride
CAS Number: 87248-13-3
Formula: C30H40NO4Cl
Formula Weight: 514.1
Linear Formula: C30H40NO4Cl
MDL No.: MFCD04113055
Purity: >=98% (HPLC)
Melting Point: 127-128 C
Storage: -20C
UNSPSC Code: 12352200
Features and Benefits: This compound is featured on the Prostanoid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
Features and Benefits: This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Biochem/physiol Actions: Selective TP prostanoid receptor antagonist. Inhibits U-46619-induced contraction of guinea pig trachea with IC50=1.8 nM.
RIDADR: NONH for all modes of transport
WGK Germany: 3